Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing
Urologia Internationalis · 2025
DOI: 10.1159/000543983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urologia Internationalis, 2025. Verfasst von Yong Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Organoids, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Introduction
Bladder urothelial carcinoma is highly heterogeneous and is prone to recurrence. There are many types of drugs for intravesical instillation, and there is an urgent need for reliable tumor models for individualized treatment strategies. Patient-derived organoids (PDOs) are efficient and accurate neotype tumor models that can compensate for the deficiencies of traditional tumor models.
Methods
From September 2023 to February 2024, bladder cancer tissues were collected from surgical resections in the Department of Urology, Beijing Tiantan Hospital, Capital Medical University. We explored suitable culture systems and cultured primary tumor cells in Matrigel matrix gels. Hematoxylin and eosin (HE) staining and immunohistochemistry were performed for comparison with the original tumor tissue at the histological level for validation. Drug sensitivity tests were also conducted.
Results
In this study, a culture system for PDOs was successfully established. HE staining and immunohistochemistry were used to morphologically verify the organ model. Drug sensitivity tests have clarified the value of PDOs as preclinical models of precision medicine.
Conclusion
A bladder tumor PDO culture platform was initially established, which laid a foundation for the subsequent construction of the organoid bank, the study of bladder tumor progression mechanism, and research in precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, liurunze910@outlook.com.
Zitieren
APA
Zhang, Y., Liu, R., Zhang, Y., & Zhou, Z. (2025). Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing. Urologia Internationalis. https://doi.org/10.1159/000543983
Vancouver
Zhang Y, Liu R, Zhang Y, Zhou Z. Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing. Urologia Internationalis. 2025. doi:10.1159/000543983
BibTeX
@article{Zhang2025,
author = {Zhang, Yong and Liu, Runze and Zhang, Yong and Zhou, Zhongbao},
title = {Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing},
journal = {Urologia Internationalis},
year = {2025},
doi = {10.1159/000543983}
}
EUVIMED